Akebia Therapeutics Inc. (AKBA) gained 5.59% or 0.59 to $11.14. It is near 396281 shares traded, which is 112.97% compare to the average total volume 350783. The market cap of AKBA is $633.68 million. The year to date change is 529.67%. The 52 week price range is from $8.93 to $20.25. Price of AKBA have changed 4.56% during last week. It have changed 1.15% over last month, -16.20% over last 3 months, -32.11% over last 6 months and -25.18% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKBA is 9.87. It is -11.40% below current price. The 200-day Moving Averages for AKBA is 14.15. It is 27.02% above current price. The 52-week High is 20.25. It is 81.78% from the current price. The 52-week Low is 8.93. It is -19.84% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKBA is 9.94 on 2018-05-31. Short % to float is 5.57%. There are some statistics of AKBA. It is has market cap $633.68 million. The share outstanding is 56.88 million. The average volume is 350783. The revenue is 69.80M. The percent of top 15 Institution holding is 62.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKBA is -47.98%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKBA is -15.02%.